Skip to main content

Table 1 Patients with IPF indicated clear needs for information in three areas

From: Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients’ perspectives of the disease and treatment

IPF Pirfenidone Updates on new research and therapies
Greater knowledge about IPF, the causes of the disease and the number of people affected More data regarding the efficacy and tolerability of pirfenidone, including how to practically manage tolerability issues Information on the new drugs that are being studied for IPF, including results from clinical trials
  1. IPF idiopathic pulmonary fibrosis